Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Randomized clinical trials for colorectal cancer peritoneal surface malignancy.

Avital I, Brücher BL, Nissan A, Stojadinovic A.

Surg Oncol Clin N Am. 2012 Oct;21(4):665-88. doi: 10.1016/j.soc.2012.07.004. Review.

PMID:
23021723
2.

Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology.

Knowles SM, Wu AM.

J Clin Oncol. 2012 Nov 1;30(31):3884-92. doi: 10.1200/JCO.2012.42.4887. Epub 2012 Sep 17.

3.

Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model.

Stojadinovic A, Bilchik A, Smith D, Eberhardt JS, Ward EB, Nissan A, Johnson EK, Protic M, Peoples GE, Avital I, Steele SR.

Ann Surg Oncol. 2013 Jan;20(1):161-74. doi: 10.1245/s10434-012-2555-4. Epub 2012 Aug 17.

PMID:
22899001
4.

Tumor response criteria: are they appropriate?

Brücher BL, Bilchik A, Nissan A, Avital I, Stojadinovic A.

Future Oncol. 2012 Aug;8(8):903-6. doi: 10.2217/fon.12.78. No abstract available.

PMID:
22894663
5.

HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?

Hompes D, Tiek J, Wolthuis A, Fieuws S, Penninckx F, Van Cutsem E, D'Hoore A.

Ann Oncol. 2012 Dec;23(12):3123-9. doi: 10.1093/annonc/mds173. Epub 2012 Jul 25.

PMID:
22831982
6.

Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.

Sangisetty SL, Miner TJ.

World J Gastrointest Surg. 2012 Apr 27;4(4):87-95. doi: 10.4240/wjgs.v4.i4.87.

7.

Tumor heterogeneity and personalized medicine.

Longo DL.

N Engl J Med. 2012 Mar 8;366(10):956-7. doi: 10.1056/NEJMe1200656. No abstract available.

PMID:
22397658
8.

Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics.

Brücher BL, Piso P, Verwaal V, Esquivel J, Derraco M, Yonemura Y, Gonzalez-Moreno S, Pelz J, Königsrainer A, Ströhlein M, Levine EA, Morris D, Bartlett D, Glehen O, Garofalo A, Nissan A.

Cancer Invest. 2012 Mar;30(3):209-24. doi: 10.3109/07357907.2012.654871. Review.

PMID:
22360361
9.

Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes.

Levine EA, Blazer DG 3rd, Kim MK, Shen P, Stewart JH 4th, Guy C, Hsu DS.

J Am Coll Surg. 2012 Apr;214(4):599-606; discussion 606-7. doi: 10.1016/j.jamcollsurg.2011.12.028. Epub 2012 Feb 17.

10.

Second-look surgery for colorectal cancer: revised selection factors and new treatment options for greater success.

Sugarbaker PH.

Int J Surg Oncol. 2011;2011:915078. doi: 10.1155/2011/915078. Epub 2010 Dec 5.

11.

Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ.

J Clin Oncol. 2012 Jan 20;30(3):263-7. doi: 10.1200/JCO.2011.37.1039. Epub 2011 Dec 12.

12.

[Advanced poorly differentiated adenocarcinoma of the colon with micropapillary carcinoma components except specific cytokeratin expressions, report of a case].

Takahashi S, Kuroiwa G, Hirayama M, Tobioka H.

Nihon Shokakibyo Gakkai Zasshi. 2011 Dec;108(12):2016-22. Japanese.

PMID:
22139489
13.

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

Gray RG, Quirke P, Handley K, Lopatin M, Magill L, Baehner FL, Beaumont C, Clark-Langone KM, Yoshizawa CN, Lee M, Watson D, Shak S, Kerr DJ.

J Clin Oncol. 2011 Dec 10;29(35):4611-9. doi: 10.1200/JCO.2010.32.8732. Epub 2011 Nov 7.

PMID:
22067390
14.

Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis.

Elias D, Honoré C, Dumont F, Ducreux M, Boige V, Malka D, Burtin P, Dromain C, Goéré D.

Ann Surg. 2011 Aug;254(2):289-93. doi: 10.1097/SLA.0b013e31822638f6.

PMID:
21709543
15.

Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Glockzin G, Renner P, Popp FC, Dahlke MH, von Breitenbuch P, Schlitt HJ, Piso P.

Ann Surg Oncol. 2011 Apr;18(4):1052-9. doi: 10.1245/s10434-010-1415-3. Epub 2010 Nov 3.

PMID:
21046262
16.

Revised guidelines for second-look surgery in patients with colon and rectal cancer.

Sugarbaker PH.

Clin Transl Oncol. 2010 Sep;12(9):621-8. doi: 10.1007/s12094-010-0567-8. Review.

PMID:
20851803
17.

Peritoneal elastic laminal invasion of colorectal cancer: the diagnostic utility and clinicopathologic relationship.

Kojima M, Nakajima K, Ishii G, Saito N, Ochiai A.

Am J Surg Pathol. 2010 Sep;34(9):1351-60. doi: 10.1097/PAS.0b013e3181ecfe98.

PMID:
20716999
18.

Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends.

Maggiori L, Elias D.

Eur J Surg Oncol. 2010 Jul;36(7):599-603. doi: 10.1016/j.ejso.2010.05.007. Review.

PMID:
20605396
19.
20.

Angiogenesis and lymphangiogenesis of gastric cancer.

Kitadai Y.

J Oncol. 2010;2010:468725. doi: 10.1155/2010/468725. Epub 2010 Mar 29.

Supplemental Content

Support Center